Quantitative analysis of nuclear shape in oral squamous cell carcinoma is useful for predicting the chemotherapeutic response

Maki Ogura, Yoichiro Yamamoto, Hitoshi Miyashita, Hiroyuki Kumamoto, Manabu Fukumoto

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)


The number of people afflicted with oral carcinoma in Japan has increased in recent years. Although preoperative neoadjuvant therapy with cisplatin and 5-fluorouracil are performed, chemotherapeutic response varies widely among the patients. With the aim of establishing novel indices to predict the therapeutic response to chemotherapy, we investigated the relationship between morphological features of pre-treatment oral carcinoma nuclei and the chemotherapeutic response using quantifying morphology of cell nuclei in pathological specimen images. We measured 4 morphological features of the nucleus of oral squamous cell carcinoma cases classified by the response to chemotherapy: No Change (NC) group, Partial Response (PR) group and Complete Response (CR) group. Furthermore, we performed immunohistochemical staining for p53 and Ki67 and calculated their positive rates in cancer tissues. Compactness and symmetry of the nucleus were significantly higher and nuclear edge response was significantly lower in cancer cells with lower chemotherapeutic responses compared high chemotherapeutic responders. As for positive rates of p53 and Ki67, there were no significant differences between any of the response groups. Morphological features of cancer cell nuclei in pathological specimens are sensitive predictive factors for the chemotherapeutic response to oral squamous cell carcinoma.

Original languageEnglish
Pages (from-to)76-82
Number of pages7
JournalMedical Molecular Morphology
Issue number2
Publication statusPublished - 2016 Jun 1


  • Chemotherapy
  • Digital pathology
  • Morphology
  • Oral squamous cell carcinoma
  • Quantitative analysis


Dive into the research topics of 'Quantitative analysis of nuclear shape in oral squamous cell carcinoma is useful for predicting the chemotherapeutic response'. Together they form a unique fingerprint.

Cite this